Interventions for fatigue in peripheral neuropathy

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  White, Claire Margaret ^a   Van Doorn, Pieter A ^b   Garssen, Marcel P J ^c   Stockley, Rachel C ^d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c JEROEN BOSCH HOSPITAL   (Netherlands)

^d Physiotherapy   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; COGNITIVE THERAPY; FATIGUE; HUMAN; ORTHOTICS; OUTCOME ASSESSMENT; PATIENT COUNSELING; PERIPHERAL NEUROPATHY; PHYSICAL ACTIVITY; QUALITY OF LIFE; RATING SCALE; RELAXATION TRAINING; REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION;

EID: 77950168890     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008146     Document Type: Review

References (27)

1. Bigland-Ritchie 1978 Bigland-Ritchie B, Jones DA, Hosking GP, Edwards RH. Central and peripheral fatigue in sustained maximum voluntary contractions of human quadriceps muscle. Clinical Science and Molecular Medicine 1978;54(6):609-14.
2. Bleijenberg 2003 Bleijenberg G. Chronic fatigue and chronic fatigue syndrome in the general population. Health and Quality of Life Outcomes 2003;1 (Oct 6):52.
3. Cappelen-Smith 2000 Cappelen-Smith C, Kuwabara S, Lin CS, Mogyoros I, Burke D. Activity-dependent hyperpolarization and conduction block in chronic inflammatory demyelinating polyneuropathy. Annals of Neurology 2000;48(6):826-32.
4. Chalder 1993 Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, Wallace EP. Development of a fatigue scale. Journal of Psychosmatic Research 1993;37(2):147-53.
5. Fisk 1994 Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clinical Infectious Diseases 1994;18(Suppl 1): S79-83.
6. Fisk 2002 Fisk JD, Doble SE. Construction and validation of a fatigue impact scale for daily administration (D-FIS). Quality of Life Research 2002;11(3):263-72.
7. Gandevia 2001 Gandevia SC. Spinal and supraspinal factors in human muscle fatigue. Physiological Reviews 2001;81(4):1725-89.
8. Garssen 2006 Garssen MP, Schmitz PI, Merkies IS, Jacobs BC, van der Meche FG, van Doorn PA. Amantadine for treatment of fatigue in Guillain-Barré syndrome: a randomised, double blind, placebo controlled, crossover trial. Journal of Neurology, Neurosurgery and Psychiatry 2006;77(1):61-5.
9. Garssen 2007 Garssen MP, Schillings ML, van Doorn PA, Van Engelen BG, Zwarts MJ. Contribution of central and peripheral factors to residual fatigue in Guillain-Barré syndrome. Muscle & Nerve 2007; 36(1):93-9.
10. Higgins 2008 Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions 5.0.0 [updated February 2008].. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
11. Kaji 2000 Kaji R, Bostock H, Kohara N, Murase N, Kimura J, Shibasaki H. Activity-dependent conduction block in multifocal motor neuropathy. Brain 2000;123(Pt 8):1602-11.
12. Karlsen 1999 Karlsen K, Larsen JP, Tandberg E, Jorgensen K. Fatigue in patients with Parkinson's disease. Movement Disorders: official journal of the Movement Disorder Society 1999;14(2):237-41.
13. Kent-Braun 1993 Kent-Braun JA, Sharma KR, Weiner MW, Massie B, Miller RG. Central basis of muscle fatigue in chronic fatigue syndrome. Neurology 1993;43(1):125-31.
14. Krupp 1989 Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of Neurology 46;10:1121-3.
15. Krupp 2003 Krupp LB. Fatigue in multiple sclerosis: definition, pathophysiology and treatment. CNS Drugs 2003;17(4):225-34.
16. Lee 1991 Lee KA, Hicks G, Nino-Murcia G. Validity and reliability of a scale to assess fatigue. Psychiatry Research 1991;36(3):291- 8.
17. Lennon 1993 Lennon SM, Koblar S, Hughes RAC, Goeller J, Riser AC. Reasons for persistent disability in Guillain-Barré syndrome. Clinical Rehabilitation 1993;7(1):1-8.
18. Martinez-Figuerora 1977 Martinez-Figueroa A, Hansen S, Ballantyne JP. A quantitative electrophysiological study of acute idiopathic polyneuritis. Journal of Neurology, Neurosurgery and Psychiatry 1977;40(2):156- 61.
19. Martyn 1998 Martyn C, Hughes RAC. Peripheral neuropathies. London: BMJ, 1998.
20. Merkies 1999 Merkies IS, Schmitz PI, Samijn JP, van der Meche FG, van Doorn PA. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Fatigue in immune-mediated polyneuropathies. Neurology 1999;53(8):1648-54.
21. Moss-Morris 2005 Moss-Morris R, Sharon C, Tobin R, Baldi JC. A randomized controlled graded exercise trial for chronic fatigue syndrome: outcomes and mechanisms of change. Journal of Health Psychology 2005;10(2):245-9.
22. Pfeiffer 2001 Pfeiffer G, Wicklein EM, Ratusinski T, Schmitt L, Kunze K. Disability and quality of life in Charcot-Marie-Tooth disease type 1. Journal of Neurology, Neurosurgery and Psychiatry 2001;70(4): 548-50.
23. Piper 1998 Piper BF, Dibble SL, Dodd MJ,Weiss MC, Slaughter RE, Paul SM. The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncology Nursing Forum 1998;25(4):677-84.
24. Pucci 2007 Pucci E, Branas P, D'Amico R, Giuliani G, Solari A, Taus C. Amantadine for fatigue in multiple sclerosis. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 1002/14651858]
25. Sanders 1996 Sanders DB, Stalberg EV, Nandedkar SD. Analysis of the electromyographic interference pattern. Journal of Clinical Neurophysiology 1996;13(5):385-400.
26. Schillings 2003 Schillings ML, Hoefsloot W, Stegeman DF, Zwarts MJ. Relative contributions of central and peripheral factors to fatigue during a maximal sustained effort. European Journal of Applied Physiology 2003;90(5-6):562-8.
27. Tamura 2007 Tamura N, Kuwabara S, Misawa S, Kanai K, Nakata M, Sawai S, et al. Time course of axonal regeneration in acute motor axonal neuropathy. Muscle & Nerve 2007;35(6):793-5.